About Nielsen BioSciences
Nielsen BioSciences, Inc. is a privately-held, San Diego-based biopharmaceutical company focused on developing and commercializing biological products with wide-ranging applications of cell-mediated immune responses.
(Candida albicans Skin Test Antigen For Cellular Hypersensitivity)
The only FDA-approved delayed-type hypersensitivity (DTH) Candida albicans extract-based skin test antigen available to assess cell-mediated immunity.
CANDIN may be useful in evaluating patients suspected of having reduced cellular immune response (Anergy).
(Coccidioides immitis Spherule-Derived Skin Test Antigen)
The only FDA-approved skin test antigen to assess cell-mediated immunity to Coccidioides, the causative agent of Valley Fever (coccidioidomycosis). Commonly referred to as the “Valley Fever Skin Test”.
The use of SPHERUSOL to detect delayed-type hypersensitivity response in a general population with unknown exposure to Coccidioides has not been evaluated.
Persons with acute or disseminated coccidioidomycosis may not develop a delayed-type hypersensitivity response to SPHERUSOL.
Persons with immunodeficiency and a history of coccidioidomycosis may not develop a delayed-type hypersensitivity response to SPHERUSOL
Nielsen BioSciences, Inc. is a privately-held, San Diego-based biopharmaceutical company focused on developing and commercializing biological products with wide-ranging applications of cell-mediated immune responses.